% Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. Beam Therapeutics Inc Most stock quote data provided by BATS. Beam Therapeutics started at overweight with $31 stock price target at J.P. Morgan Mar.
Apple reportedly has purchased startup for phone payment processing: report Find the latest Beam Therapeutics Inc. (BEAM) stock discussion in Yahoo Finance's forum. Disclaimer.
Its programs are organized by delivery modality into three distinct pipelines: electroporation for delivery to blood cells and immune cells; lipid nanoparticles (LNPs), for non-viral in vivo delivery to the liver and potentially other organs in the future; and adeno-associated viral vectors (AAV), for viral delivery to the eye and central nervous system (CNS).As of Real time Beam Therapeutics (BEAM) stock price quote, stock graph, news & analysis.
%Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks ET by Tomi Kilgore Beam Therapeutics started at …
One share of BEAM stock can currently be purchased for approximately $21.26. Beam is pursuing two differentiated base editing approaches to treat hemoglobinopathies: its hereditary persistence of fetal hemoglobin (HPFH) program to precisely and robustly elevate fetal hemoglobin, which could be used in treatments for both sickle cell disease and beta-thalassemia, as well as a novel approach to directly correct the sickle causing point mutation (Makassar).Analyst Report: Fortune Brands Home & Security, Inc.Analyst Report: Fortune Brands Home & Security, Inc.Discover new investment ideas by accessing unbiased, in-depth investment researchNasdaqGS - NasdaqGS Real Time Price.
All rights reserved. Speculative. Find real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. − How big of a company is Beam Therapeutics? Higher net loss reflects Research and development - Balanc increase from $8.7M to $19.8M (expense). $25.09 0.1 0.2% Last Trade - 14/07/20. BEAM - Beam Therapeutics Inc Share Price. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. %
The all-time high Beam Therapeutics stock closing price was 30.57 on July 09, 2020.; The Beam Therapeutics 52-week high stock price is 31.80, which is 30.2% above the current share price. The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. © Stockopedia 2020, Refinitiv, Share Data Services.
Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Beam Therapeutics against related stocks people have also bought. 2, 2020 at 8:56 a.m. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Copyright © 2020 MarketWatch, Inc. All rights reserved. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates.
0.000 Hammerson in talks over disposals, equity raise Shares in Beam Therapeutics Inc are currently trading at + There are no analysts currently covering Beam Therapeutics Inc.Beam Therapeutics Inc is scheduled to issue upcoming financial results on the following dates: Beam Therapeutics Inc does not currently pay a dividend.Beam Therapeutics Inc does not currently pay a dividend.Beam Therapeutics Inc does not currently pay a dividend.To buy shares in Beam Therapeutics Inc you'll need a Shares in Beam Therapeutics Inc are currently trading at Here are the trading details for Beam Therapeutics Inc:Shares in Beam Therapeutics Inc are currently priced at Analysts covering Beam Therapeutics Inc currently have a consensus Earnings Per Share (EPS) forecast of An important predictor of whether a stock price will go up is its track record of momentum.